Volume 27, Number 4—April 2021
CME ACTIVITY - Synopsis
Blastomycosis Surveillance in 5 States, United States, 1987–2018
Table 3
Characteristic | Hospitalization |
Death |
|||
---|---|---|---|---|---|
RR (95% CI) | p value | RR (95% CI) | p value | ||
Older age | NA | 0.015 | NA | <0.001 | |
Female sex | 1.13 (1.05–1.21) | <0.001 | 1.05 (0.83–1.33) | 0.681 | |
Non-White race | 1.13 (1.05–1.21) | 0.002 | 1.08 (0.82–1.42) | 0.588 | |
Antigen test† | 1.25 (1.13–1.37) | <0.001 | 1.27 (0.84–1.92) | 0.255 | |
Culture† | 1.28 (1.20–1.36) | <0.001 | 1.02 (0.79–1.33) | 0.864 | |
Microscopy† | 1.32 (1.23–1.43) | <0.001 | 1.76 (1.34–2.38) | <0.001 |
*NA, not applicable; RR, relative risk. †Arkansas, Michigan, and Minnesota only.
Page created: February 09, 2021
Page updated: March 17, 2021
Page reviewed: March 17, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.